A study to determine immunogenicity of mRNA-based SARS-CoV-2 vaccines in paediatric patients with inflammatory bowel disease treated with anti-TNF therapies
Latest Information Update: 30 Nov 2021
At a glance
- Drugs Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
- 30 Nov 2021 New trial record
- 23 Nov 2021 Results (n=42) of preliminary analysis published in the Gut